1-(3-(1H-Imidazol-1-yl)propyl)-5-(3-bromo-4-hydroxy-5-methoxyphenyl)-4-(3-fluoro-4-methylbenzoyl)-3-hydroxy-1H-pyrrol-2(5H)-one

Catalog No. :
ACWUWA567
CAS No. :
618076-03-2
Molecular Formula :
C25H23BrFN3O5
Molecular Weight :
544.38

IUPAC Name:1-(3-(1H-imidazol-1-yl)propyl)-5-(3-bromo-4-hydroxy-5-methoxyphenyl)-4-(3-fluoro-4-methylbenzoyl)-3-hydroxy-1,5-dihydro-2H-pyrrol-2-one

1-(3-(1H-Imidazol-1-yl)propyl)-5-(3-bromo-4-hydroxy-5-methoxyphenyl)-4-(3-fluoro-4-methylbenzoyl)-3-hydroxy-1H-pyrrol-2(5H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(3-(1H-Imidazol-1-yl)propyl)-5-(3-bromo-4-hydroxy-5-methoxyphenyl)-4-(3-fluoro-4-methylbenzoyl)-3-hydroxy-1H-pyrrol-2(5H)-one
IUPAC Name1-(3-(1H-imidazol-1-yl)propyl)-5-(3-bromo-4-hydroxy-5-methoxyphenyl)-4-(3-fluoro-4-methylbenzoyl)-3-hydroxy-1,5-dihydro-2H-pyrrol-2-one
MDL No.MFCD04442230
Molecular FormulaC25H23BrFN3O5
Molecular Weight544.38
SMILESCOC1=C(O)C(Br)=CC(C2C(C(=O)C3=CC=C(C)C(F)=C3)=C(O)C(=O)N2CCCN2C=CN=C2)=C1
InChI KeyNQLRKRHMZCJAOM-UHFFFAOYSA-N
SynonymSALOR-INT L430013-1EA;5-(3-BROMO-4-HYDROXY-5-METHOXYPHENYL)-4-(3-FLUORO-4-METHYLBENZOYL)-3-HYDROXY-1-[3-(1H-IMIDAZOL-1-YL)PROPYL]-1,5-DIHYDRO-2H-PYRROL-2-ONE
CAS No.618076-03-2

Synthetic Route by SureRoute

1. ACWUWA567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDLYM406 route compound structure diagram
    ACDLYM4065587-42-8 In Stock
  4. Then
  5. ACWUWA567 route product structure diagram
    ACWUWA567618076-03-2
Inquiry

2. ACWUWA567 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWUWA567 route product structure diagram
    ACWUWA567618076-03-2
Inquiry

Comments (0)